Intended for healthcare professionals


European agency approves swine flu vaccines for licensing

BMJ 2009; 339 doi: (Published 29 September 2009) Cite this as: BMJ 2009;339:b3992

This article has a correction. Please see:

  1. Sophie Cook
  1. 1BMJ

    Two swine flu vaccines, including one of those to be used in the United Kingdom’s vaccination programme, were approved for licensing by the European Medicines Agency on 25 September.

    The agency’s committee for medicinal products for human use expedited the assessment of the vaccines—Focetria from Novartis and Pandemrix from GlaxoSmithKline—and recommended that they be granted a licence by the European Commission.

    The Department of Health for England said, “This is a positive step towards getting full licences for vaccines to protect the public. The European Commission must now consider the recommendations, and we hope for its decision as quickly …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription